Restless legs syndrome, sleep impairment, and fatigue in chronic obstructive pulmonary disease.

Cavalcante AG, de Bruin PF, de Bruin VM, Pereira ED, Cavalcante MM, Nunes DM, Viana CS.

Sleep Med. 2012 Aug;13(7):842-7. doi: 10.1016/j.sleep.2012.03.017.

Frequency, severity and risk factors for restless legs syndrome in healthcare personnel.

Civi S, Kutlu R, Tokgoz S.

Neurosciences (Riyadh). 2012 Jul;17(3):230-5.

Exome sequencing in a family with restless legs syndrome.

Weissbach A, Siegesmund K, Brüggemann N, Schmidt A, Kasten M, Pichler I, Muhle H, Lohmann E, Lohnau T, Schwinger E, Hagenah J, Stephani U, Pramstaller PP, Klein C, Lohmann K.

Mov Disord. 2012 Nov;27(13):1686-9. doi: 10.1002/mds.25191.

Role of gabapentin enacarbil XR in restless legs syndrome.

Sivam S, Yee BJ.

Ther Clin Risk Manag. 2012;8:201-8. doi: 10.2147/TCRM.S24436.

Dose response of Gabapentin Enacarbil versus placebo in subjects with moderate-to-severe primary restless legs syndrome: an integrated analysis of three 12-week studies.

VanMeter SA, Kavanagh ST, Warren S, Barrett RW.

CNS Drugs. 2012 Sep 1;26(9):773-80. doi: 10.2165/11634870-000000000-00000.

Restless legs syndrome in Czech patients with multiple sclerosis: an epidemiological and genetic study.

Vávrová J, Kemlink D, Sonka K, Havrdová E, Horáková D, Pardini B, Müller-Myhsok B, Winkelmann J.

Sleep Med. 2012 Aug;13(7):848-51. doi: 10.1016/j.sleep.2012.03.012.

Restless legs syndrome responsive to rasagiline treatment: a case report.

Babacan-Yildiz G, Gursoy E, Kolukisa M, Celebi A.

Clin Neuropharmacol. 2012 Mar-Apr;35(2):88-9. doi: 10.1097/WNF.0b013e31824c1c3f.

Restless legs syndrome and risk of incident cardiovascular disease in women and men: prospective cohort study.

Winter AC, Schürks M, Glynn RJ, Buring JE, Gaziano JM, Berger K, Kurth T.

BMJ Open. 2012 Mar 23;2(2):e000866. doi: 10.1136/bmjopen-2012-000866.

Methoxy polyethylene glycol-epoetin beta (CERA) induced restless legs syndrome.

Inal S, Gölbaş C, Oneç K, Okyay GU, Derici UB.

Ther Apher Dial. 2012 Aug;16(4):378-9. doi: 10.1111/j.1744-9987.2012.01076.x. No abstract available.

Ten-year natural course of habitual snoring and restless legs syndrome in a population aged 61-63 years at the baseline.

Juuti AK, Hiltunen L, Rajala U, Laakso M, Härkönen P, Keinänen-Kiukaanniemi S, Läärä E.

Sleep Breath. 2012 Sep;16(3):639-48. doi: 10.1007/s11325-011-0551-8.

Risk factors and prevalence rate of restless legs syndrome among pregnant women in Taiwan.

Chen PH, Liou KC, Chen CP, Cheng SJ.

Sleep Med. 2012 Oct;13(9):1153-7. doi: 10.1016/j.sleep.2012.06.008.

A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome.

Lal R, Ellenbogen A, Chen D, Zomorodi K, Atluri H, Luo W, Tovera J, Hurt J, Bonzo D, Lassauzet ML, Vu A, Cundy KC.

Clin Neuropharmacol. 2012 Jul-Aug;35(4):165-73. doi: 10.1097/WNF.0b013e318259eac8.

Prevalence of restless legs syndrome in a Georgian primary healthcare setting: a pilot study.

Kuchukhidze G, Toidze I, Khatiashvili I, Maisuradze L, Frauscher B, Kasradze S, Högl B.

Eur Neurol. 2012;68(3):177-80.

In vivo mesolimbic D2/3 receptor binding predicts posttherapeutic clinical responses in restless legs syndrome: a positron emission tomography study.

Oboshi Y, Ouchi Y, Yagi S, Kono S, Nakai N, Yoshikawa E, Futatsubashi M, Terada T, Kim K, Harada K.

J Cereb Blood Flow Metab. 2012 Apr;32(4):654-62. doi: 10.1038/jcbfm.2011.201.

Restless legs syndrome in dialysis patients: a comparison between hemodialysis and continuous ambulatory peritoneal dialysis.

Merlino G, Lorenzut S, Romano G, Sommaro M, Fontana A, Montanaro D, Valente M, Gigli GL.

Neurol Sci. 2012 Dec;33(6):1311-8. doi: 10.1007/s10072-012-0953-9.